Clinical Trials
3 trialsNCT02172911 2021-02-21
A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer
Inovio Pharmaceuticals
Phase 1/2 Completed
NCT01188850 2018-08-10
Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100
Inovio Pharmaceuticals
Phase 1 Completed
NCT00685412 2017-09-13
Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3
Inovio Pharmaceuticals
Phase 1 Completed